Unresectable locally advanced pancreatic cancer
Conditions
Interventions
Three hours before the middle of the 6-hour fasting period, the patient should take a pharmaceutical nutritional supplement that is adopted by the hospital. The radiologist adjusts the timing of irra
s pre-treatment dietary habits and select the best time to incorporate the treatment into the patient'
s lifestyle. The nurse use the treatment diary to check dietary intake and treatment adverse events daily from the first day of irradiation to the last day of irradiation.
Sponsors
Orhers
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing radical proton therapy for pancreatic cancer at our Proton Therapy Center. Patients diagnosed with unresectable locally advanced pancreatic cancer. Patients must be at least 20 years of age to obtain consent. Patients must be covered by insurance. Patients must have a performance status of 0 to 2.
Exclusion criteria
Exclusion criteria: Patients with distant metastases or peritoneal dissemination. Pediatric patients. Patients who have been determined to have difficulty using the pharmaceutical nutritional products used in this study. Patients who consume other than the pharmaceutical nutritional products used in this study during the fasting period. Patients who are deemed by the treating physician to be unsuitable for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weigh the patients at the beginning of proton therapy, at the 10th irradiation, on the last day of treatment, and one month after completion of treatment, and measure the percentage of weight loss. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Compare quality of life assessments before treatment and one month after treatment completion with the EORTC QOL-C30. 2. Overall surivival | — |
Countries
Japan
Contacts
Public ContactShoko Kurano
JISENKAI Healthcare Incorporated Foundation, Aizawa Hospital Aizawa Comprehensive Cancer Center
Outcome results
None listed